相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool
Nicolas Nicastro et al.
JOURNAL OF NEUROCHEMISTRY (2023)
18F-MK-6240 tau-PET in genetic frontotemporal dementia
Jake P. Levy et al.
BRAIN (2022)
Cortical microstructure in primary progressive aphasia: a multicenter study
Ignacio Illan-Gala et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
Ruiqing Ni et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations
Bradley F. Boeve et al.
LANCET NEUROLOGY (2022)
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Lingling Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Autosomal Dominant Frontotemporal Lobar Degeneration in a Filipino Family with Progranulin Mutation
Jacqueline Dominguez et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2021)
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies
Kenji Tagai et al.
NEURON (2021)
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
Maria Ricci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers
Mica T. M. Clarke et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration
Ignacio Illan-Gala et al.
JAMA NETWORK OPEN (2021)
Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease
Steven Y. Yap et al.
BRAIN (2021)
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency A Randomized Clinical Trial
Peter A. Ljubenkov et al.
JAMA NETWORK OPEN (2021)
FDG-PET in presymptomatic C9orf72 mutation carriers
Karteek Popuri et al.
NEUROIMAGE-CLINICAL (2021)
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
Antoine Leuzy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Synaptic density in carriers of C9orf72 mutations: a [11C] UCB-J PET study
Maura Malpetti et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation
Bin Deng et al.
AGING AND DISEASE (2021)
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
Maura Malpetti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Longitudinal (18F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation
Rhian S. Convery et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment
Neus Falgas et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation
Ya Su et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
Joke De Vocht et al.
JAMA NEUROLOGY (2020)
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Tharick A. Pascoal et al.
BRAIN (2020)
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations
Abigail Licata et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
PET imaging of neuroinflammation in neurological disorders
William C. Kreisl et al.
LANCET NEUROLOGY (2020)
C9ORF72 hexanucleotide repeat expansion with Alzheimer's disease-like clinical phenotype: A case report with results from neuropsychology, CSF, FDG-PET, and PiB-PET
Zuhal Filikci et al.
CLINICAL CASE REPORTS (2020)
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases
David N. Soleimani-Meigooni et al.
BRAIN (2020)
A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype epsilon 4/epsilon 4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report
Maurizio Gallucci et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Kevin H. Strang et al.
LABORATORY INVESTIGATION (2019)
Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features
Aya Ikeda et al.
MOVEMENT DISORDERS (2019)
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
Richard M. Tsai et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
Janine Diehl-Schmid et al.
TRANSLATIONAL PSYCHIATRY (2019)
18F-Flortaucipir in TDP-43 associated frontotemporal dementia
R. Smith et al.
SCIENTIFIC REPORTS (2019)
Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion
Leila Sellami et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2019)
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Yi Ting Wang et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
[18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window
Julien Lagarde et al.
JOURNAL OF NEUROLOGY (2019)
Bifrontal Hypermetabolism on Brain FDG-PET in a Case of C9orf72-Related Behavioral Variant of Frontotemporal Dementia
Jake P. Levy et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Tau PET imaging in neurodegenerative tauopathies-still a challenge
Antoine Leuzy et al.
MOLECULAR PSYCHIATRY (2019)
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation
Veronica Castelnovo et al.
NEUROLOGICAL SCIENCES (2019)
In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier
W. Richard Bevan-Jones et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset
Liyong Wu et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia
Julia Kraemer et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation
F. Ali et al.
JOURNAL OF NEUROLOGY (2018)
In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
David T. Jones et al.
NEUROLOGY (2018)
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies
Iris Broce et al.
PLOS MEDICINE (2018)
Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET
Udunna C. Anazodo et al.
NEUROIMAGE-CLINICAL (2018)
[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
Richard W. Bevan-Jones et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review
Shuang He et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET
David Fallmar et al.
EUROPEAN RADIOLOGY (2017)
PBB3 Imaging in Parkinsonian Disorders: Evidence for Binding to Tau and Other Proteins
Alexandra Perez-Soriano et al.
MOVEMENT DISORDERS (2017)
Imaging and fluid biomarkers in frontotemporal dementia
Lieke H. Meeter et al.
NATURE REVIEWS NEUROLOGY (2017)
Frontotemporal dementia with the V337M MAPT mutation Tau-PET and pathology correlations
Salvatore Spina et al.
NEUROLOGY (2017)
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
Maiko Ono et al.
BRAIN (2017)
Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?
Sharon J. Sha et al.
NEUROCASE (2016)
Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers
Nikolas R. Block et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Ruben Smith et al.
BRAIN (2016)
Genetics of FTLD: overview and what else we can expect from genetic studies
Cyril Pottier et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
Nabeel B. Nabulsi et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
A perspective on the future role of brain pet imaging in exercise science
Henning Boecker et al.
NEUROIMAGE (2016)
Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD
Duygu Tosun et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
[18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
W. Richard Bevan Jones et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Adam C. Kaufman et al.
ANNALS OF NEUROLOGY (2015)
Closing the tau loop: the missing tau mutation
Allan McCarthy et al.
BRAIN (2015)
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
Sander C. J. Verfaillie et al.
EUROPEAN RADIOLOGY (2015)
The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
Eino Solje et al.
PLOS ONE (2015)
Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism
Yang Yang et al.
PLOS ONE (2015)
Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
Christian Vogl et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Paola Caroppo et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: a case report
Carla Gramaglia et al.
BMC NEUROLOGY (2014)
Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old
John L. Robinson et al.
BRAIN (2014)
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients
Angelina Cistaro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Evidence of Pre-Synaptic Dopaminergic Deficit in a Patient with a Novel Progranulin Mutation Presenting with Atypical Parkinsonism
Miryam Carecchio et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Progranulin-associated PiB-negative logopenic primary progressive aphasia
Keith A. Josephs et al.
JOURNAL OF NEUROLOGY (2014)
Brain 18F-FDG and 11C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion
Mika H. Martikainen et al.
NEUROCASE (2014)
Patterns of microglial cell activation in frontotemporal lobar degeneration
S. B. Lant et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
Brain perfusion single photon emission computed tomography in major psychiatric disorders: From basics to clinical practice
Amburanjan Santra et al.
INDIAN JOURNAL OF NUCLEAR MEDICINE (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Juvenile Frontotemporal Dementia with Parkinsonism Associated with Tau Mutation G389R
Marie-Pierre Chaunu et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The Neuroimaging Signature of Frontotemporal Lobar Degeneration Associated with Granulin Mutations: An Effective Connectivity Study
Enrico Premi et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers
Claudia Jacova et al.
NEUROLOGY (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
Bradley Boeve et al.
Alzheimers & Dementia (2012)
Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p
Ging-Yuek R. Hsiung et al.
BRAIN (2012)
Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand
Zsolt Cselenyi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin
E. McDade et al.
NEUROLOGY (2012)
Phenotypic signatures of genetic frontotemporal dementia
Jonathan D. Rohrer et al.
CURRENT OPINION IN NEUROLOGY (2011)
Symmetrical Corticobasal Syndrome Caused by a Novel c.314dup Progranulin Mutation
Elise G. P. Dopper et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Brain perfusion patterns in familial frontotemporal lobar degeneration
H. Seelaar et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: A PET and MRI study
Michie Miyoshi et al.
PARKINSONISM & RELATED DISORDERS (2010)
Prominent phenotypic variability associated with mutations in Progranulin
Brendan J. Kelley et al.
NEUROBIOLOGY OF AGING (2009)
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series
Jonathan Beck et al.
BRAIN (2008)
PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Janine Doorduin et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia
Simon M. Laws et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)
Zoe Arvanitakis et al.
PARKINSONISM & RELATED DISORDERS (2007)
Characteristics of frontotemporal dementia patients with a progranulin mutation
Edward D. Huey et al.
ANNALS OF NEUROLOGY (2006)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
FTDP-17 mutations compromise the ability of Tau to regulate microtubule dynamics in cells
JM Bunker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein
M Gillard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
分享论文
